MTOR and neoplasm: The signaling pathway of the mechanistic target of rapamycin (mTOR) is one of the most important signaling network downstream of the oncogenic receptor tyrosine kinases (RTKs), which participate in tumor growth, metastasis and therapy evasion (1, 2).